Sk. Kayum Alam

698 total citations
18 papers, 461 citations indexed

About

Sk. Kayum Alam is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sk. Kayum Alam has authored 18 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Sk. Kayum Alam's work include RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Lung Cancer Research Studies (3 papers). Sk. Kayum Alam is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Lung Cancer Research Studies (3 papers). Sk. Kayum Alam collaborates with scholars based in United States, India and Canada. Sk. Kayum Alam's co-authors include Luke H. Hoeppner, Li Wang, Susanta Roychoudhury, Matteo Astone, Arindam Datta, Rendong Yang, Ting-You Wang, Zhu Zhu, Pijush K. Das and Swati Bajaj and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Bioinformatics.

In The Last Decade

Sk. Kayum Alam

17 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sk. Kayum Alam United States 12 312 164 125 60 53 18 461
Yun Seong Jeong United States 9 397 1.3× 147 0.9× 143 1.1× 41 0.7× 44 0.8× 17 499
Mengxian Zhang China 8 355 1.1× 172 1.0× 135 1.1× 48 0.8× 28 0.5× 16 528
Mariam Markouli Greece 12 286 0.9× 104 0.6× 95 0.8× 65 1.1× 45 0.8× 27 469
Amr H. Allam Australia 10 193 0.6× 173 1.1× 110 0.9× 62 1.0× 56 1.1× 15 423
Ashkan Shahbandi United States 7 231 0.7× 200 1.2× 124 1.0× 112 1.9× 28 0.5× 11 507
Eva Y‐HP Lee United States 5 283 0.9× 128 0.8× 121 1.0× 58 1.0× 30 0.6× 6 409
Ramona Schulz‐Heddergott Germany 8 339 1.1× 288 1.8× 143 1.1× 64 1.1× 49 0.9× 15 531
Madhurendra Singh Sweden 12 331 1.1× 212 1.3× 69 0.6× 62 1.0× 85 1.6× 17 516
Brigitte Bisarò Italy 12 307 1.0× 172 1.0× 103 0.8× 51 0.8× 109 2.1× 16 513
M. Ángeles Villaronga Spain 17 420 1.3× 139 0.8× 162 1.3× 41 0.7× 40 0.8× 28 577

Countries citing papers authored by Sk. Kayum Alam

Since Specialization
Citations

This map shows the geographic impact of Sk. Kayum Alam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sk. Kayum Alam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sk. Kayum Alam more than expected).

Fields of papers citing papers by Sk. Kayum Alam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sk. Kayum Alam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sk. Kayum Alam. The network helps show where Sk. Kayum Alam may publish in the future.

Co-authorship network of co-authors of Sk. Kayum Alam

This figure shows the co-authorship network connecting the top 25 collaborators of Sk. Kayum Alam. A scholar is included among the top collaborators of Sk. Kayum Alam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sk. Kayum Alam. Sk. Kayum Alam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Alam, Sk. Kayum, Li Wang, Bernhard Thiele, et al.. (2025). Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression. Cell Death and Disease. 16(1). 370–370. 5 indexed citations
2.
Lawrence, Jessica, Davis Seelig, Kimberly Demos-Davies, et al.. (2024). Radiation dermatitis in the hairless mouse model mimics human radiation dermatitis. Scientific Reports. 14(1). 24819–24819.
3.
Alam, Sk. Kayum, Li Wang, Zhu Zhu, & Luke H. Hoeppner. (2023). IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity. npj Precision Oncology. 7(1). 33–33. 4 indexed citations
4.
Hartono, Stella, Victoria M. Bedell, Sk. Kayum Alam, et al.. (2021). Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury. Mayo Clinic Proceedings. 97(1). 154–164. 14 indexed citations
5.
Wang, Li, Matteo Astone, Sk. Kayum Alam, et al.. (2021). Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability. Disease Models & Mechanisms. 14(11). 52 indexed citations
6.
Alam, Sk. Kayum, Yongchang Zhang, Li Wang, et al.. (2021). DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma. Oncogene. 41(1). 83–98. 16 indexed citations
7.
Wang, Ting-You, Qi Liu, Yanan Ren, et al.. (2021). A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes. Molecular Cell. 81(10). 2246–2260.e12. 41 indexed citations
8.
Alam, Sk. Kayum, Li Wang, Yanan Ren, et al.. (2020). ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation. British Journal of Cancer. 123(5). 819–832. 18 indexed citations
9.
Wang, Ting-You, Li Wang, Sk. Kayum Alam, Luke H. Hoeppner, & Rendong Yang. (2019). ScanNeo: identifying indel-derived neoantigens using RNA-Seq data. Bioinformatics. 35(20). 4159–4161. 34 indexed citations
10.
Alam, Sk. Kayum, Matteo Astone, Ping Liu, et al.. (2019). Abstract 873: Molecular mechanisms of non-small cell lung cancer growth and drug resistance. Cancer Research. 79(13_Supplement). 873–873. 1 indexed citations
11.
Datta, Arindam, Pijush K. Das, Sanjib Dey, et al.. (2019). Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53. Genes. 10(11). 852–852. 8 indexed citations
12.
Alam, Sk. Kayum, Matteo Astone, Ping Liu, et al.. (2018). DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration. Communications Biology. 1(1). 43–43. 21 indexed citations
13.
Astone, Matteo, et al.. (2017). Fishing for cures: The alLURE of using zebrafish to develop precision oncology therapies. npj Precision Oncology. 1(1). 41 indexed citations
14.
Datta, Arindam, Sumit Das, Taraswi Banerjee, et al.. (2017). p53 gain‐of‐function mutations increase Cdc7‐dependent replication initiation. EMBO Reports. 18(11). 2030–2050. 36 indexed citations
15.
Ghuwalewala, Sangeeta, Pijush K. Das, Sk. Kayum Alam, et al.. (2016). MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features. Scientific Reports. 6(1). 23932–23932. 50 indexed citations
16.
Bajaj, Swati, et al.. (2016). E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53. Journal of Biological Chemistry. 291(27). 14231–14247. 27 indexed citations
17.
Datta, Arindam, Sanjib Dey, Pijush K. Das, Sk. Kayum Alam, & Susanta Roychoudhury. (2016). Transcriptome profiling identifies genes and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53. Genomics Data. 8. 47–51. 9 indexed citations
18.
Alam, Sk. Kayum, Vinod Kumar Yadav, Swati Bajaj, et al.. (2015). DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53. Cell Death and Differentiation. 23(4). 707–722. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026